Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance

Alfredo Ulloa-Aguirre, Lesly Portocarrero, Teresa Zariñán, Aleida Olivares, Sebastián Carranza-Lira, Johannes D Veldhuis, Juan C. López-Alvarenga

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The role of hyperinsulinaemia in neuroendocrine abnormalities in polycystic ovarian syndrome (PCOS) is controversial. The present study applied frequent blood sampling to assess the response of LH to metformin treatment in insulin-resistant women with PCOS. Thirteen predominantly overweight women with PCOS were studied before and after treatment with 1.5 g/day metformin for 3 months. Serum LH and testosterone were measured every 10 min for 10 h; LH was measured for an additional 2 h after gonadotrophin-releasing hormone (GnRH) administration. LH pulses were characterized by cluster analysis, secretory LH episodes by a deconvolution procedure, and synchronicity of paired LH-testosterone concentrations by lag-specific cross-correlation. After treatment, basal LH concentrations, amplitude of LH pulses, LH secretory amplitude, response to exogenous GnRH, and basal testosterone concentrations significantly decreased in seven patients, whereas in the remaining women these parameters remained unaltered. Before treatment, decreased coordinate LH and testosterone release was manifested by all patients; metformin treatment led to re-establishment of the feed-back control of testosterone on LH secretory rates by -20 to 0 min. Treatment did not modify the glucose:insulin ratio or serum insulin concentrations. In conclusion, administration of metformin allowed the identification of two subsets of PCOS women in whom neuroendocrine abnormalities may improve independently of the presence of insulin resistance or hyperinsulinaemia.

Original languageEnglish (US)
Article number2243
Pages (from-to)669-683
Number of pages15
JournalReproductive BioMedicine Online
Volume12
Issue number6
StatePublished - Jun 2006

Fingerprint

Polycystic Ovary Syndrome
Metformin
Insulin Resistance
Testosterone
Hyperinsulinism
Insulin
Gonadotropin-Releasing Hormone
Therapeutics
Secretory Rate
Serum
Cluster Analysis
Glucose

Keywords

  • Insulin resistance
  • LH
  • Metformin
  • Polycystic ovarian syndrome
  • Testosterone

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Ulloa-Aguirre, A., Portocarrero, L., Zariñán, T., Olivares, A., Carranza-Lira, S., Veldhuis, J. D., & López-Alvarenga, J. C. (2006). Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. Reproductive BioMedicine Online, 12(6), 669-683. [2243].

Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. / Ulloa-Aguirre, Alfredo; Portocarrero, Lesly; Zariñán, Teresa; Olivares, Aleida; Carranza-Lira, Sebastián; Veldhuis, Johannes D; López-Alvarenga, Juan C.

In: Reproductive BioMedicine Online, Vol. 12, No. 6, 2243, 06.2006, p. 669-683.

Research output: Contribution to journalArticle

Ulloa-Aguirre, A, Portocarrero, L, Zariñán, T, Olivares, A, Carranza-Lira, S, Veldhuis, JD & López-Alvarenga, JC 2006, 'Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance', Reproductive BioMedicine Online, vol. 12, no. 6, 2243, pp. 669-683.
Ulloa-Aguirre A, Portocarrero L, Zariñán T, Olivares A, Carranza-Lira S, Veldhuis JD et al. Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. Reproductive BioMedicine Online. 2006 Jun;12(6):669-683. 2243.
Ulloa-Aguirre, Alfredo ; Portocarrero, Lesly ; Zariñán, Teresa ; Olivares, Aleida ; Carranza-Lira, Sebastián ; Veldhuis, Johannes D ; López-Alvarenga, Juan C. / Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance. In: Reproductive BioMedicine Online. 2006 ; Vol. 12, No. 6. pp. 669-683.
@article{a89fbfde28d847c58a24ebb9bd6da068,
title = "Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance",
abstract = "The role of hyperinsulinaemia in neuroendocrine abnormalities in polycystic ovarian syndrome (PCOS) is controversial. The present study applied frequent blood sampling to assess the response of LH to metformin treatment in insulin-resistant women with PCOS. Thirteen predominantly overweight women with PCOS were studied before and after treatment with 1.5 g/day metformin for 3 months. Serum LH and testosterone were measured every 10 min for 10 h; LH was measured for an additional 2 h after gonadotrophin-releasing hormone (GnRH) administration. LH pulses were characterized by cluster analysis, secretory LH episodes by a deconvolution procedure, and synchronicity of paired LH-testosterone concentrations by lag-specific cross-correlation. After treatment, basal LH concentrations, amplitude of LH pulses, LH secretory amplitude, response to exogenous GnRH, and basal testosterone concentrations significantly decreased in seven patients, whereas in the remaining women these parameters remained unaltered. Before treatment, decreased coordinate LH and testosterone release was manifested by all patients; metformin treatment led to re-establishment of the feed-back control of testosterone on LH secretory rates by -20 to 0 min. Treatment did not modify the glucose:insulin ratio or serum insulin concentrations. In conclusion, administration of metformin allowed the identification of two subsets of PCOS women in whom neuroendocrine abnormalities may improve independently of the presence of insulin resistance or hyperinsulinaemia.",
keywords = "Insulin resistance, LH, Metformin, Polycystic ovarian syndrome, Testosterone",
author = "Alfredo Ulloa-Aguirre and Lesly Portocarrero and Teresa Zari{\~n}{\'a}n and Aleida Olivares and Sebasti{\'a}n Carranza-Lira and Veldhuis, {Johannes D} and L{\'o}pez-Alvarenga, {Juan C.}",
year = "2006",
month = "6",
language = "English (US)",
volume = "12",
pages = "669--683",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance

AU - Ulloa-Aguirre, Alfredo

AU - Portocarrero, Lesly

AU - Zariñán, Teresa

AU - Olivares, Aleida

AU - Carranza-Lira, Sebastián

AU - Veldhuis, Johannes D

AU - López-Alvarenga, Juan C.

PY - 2006/6

Y1 - 2006/6

N2 - The role of hyperinsulinaemia in neuroendocrine abnormalities in polycystic ovarian syndrome (PCOS) is controversial. The present study applied frequent blood sampling to assess the response of LH to metformin treatment in insulin-resistant women with PCOS. Thirteen predominantly overweight women with PCOS were studied before and after treatment with 1.5 g/day metformin for 3 months. Serum LH and testosterone were measured every 10 min for 10 h; LH was measured for an additional 2 h after gonadotrophin-releasing hormone (GnRH) administration. LH pulses were characterized by cluster analysis, secretory LH episodes by a deconvolution procedure, and synchronicity of paired LH-testosterone concentrations by lag-specific cross-correlation. After treatment, basal LH concentrations, amplitude of LH pulses, LH secretory amplitude, response to exogenous GnRH, and basal testosterone concentrations significantly decreased in seven patients, whereas in the remaining women these parameters remained unaltered. Before treatment, decreased coordinate LH and testosterone release was manifested by all patients; metformin treatment led to re-establishment of the feed-back control of testosterone on LH secretory rates by -20 to 0 min. Treatment did not modify the glucose:insulin ratio or serum insulin concentrations. In conclusion, administration of metformin allowed the identification of two subsets of PCOS women in whom neuroendocrine abnormalities may improve independently of the presence of insulin resistance or hyperinsulinaemia.

AB - The role of hyperinsulinaemia in neuroendocrine abnormalities in polycystic ovarian syndrome (PCOS) is controversial. The present study applied frequent blood sampling to assess the response of LH to metformin treatment in insulin-resistant women with PCOS. Thirteen predominantly overweight women with PCOS were studied before and after treatment with 1.5 g/day metformin for 3 months. Serum LH and testosterone were measured every 10 min for 10 h; LH was measured for an additional 2 h after gonadotrophin-releasing hormone (GnRH) administration. LH pulses were characterized by cluster analysis, secretory LH episodes by a deconvolution procedure, and synchronicity of paired LH-testosterone concentrations by lag-specific cross-correlation. After treatment, basal LH concentrations, amplitude of LH pulses, LH secretory amplitude, response to exogenous GnRH, and basal testosterone concentrations significantly decreased in seven patients, whereas in the remaining women these parameters remained unaltered. Before treatment, decreased coordinate LH and testosterone release was manifested by all patients; metformin treatment led to re-establishment of the feed-back control of testosterone on LH secretory rates by -20 to 0 min. Treatment did not modify the glucose:insulin ratio or serum insulin concentrations. In conclusion, administration of metformin allowed the identification of two subsets of PCOS women in whom neuroendocrine abnormalities may improve independently of the presence of insulin resistance or hyperinsulinaemia.

KW - Insulin resistance

KW - LH

KW - Metformin

KW - Polycystic ovarian syndrome

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=33745049764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745049764&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 669

EP - 683

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 6

M1 - 2243

ER -